ABBV-303

• Target :

  ADC Antibody|||c-Met/HGFR

• Related Pathways :

  Antibody-drug Conjugate/ADC Related|||Tyrosine Kinase/Adaptors

• Bioactivity :

  ABBV-303 is a multispecific NK cell antibody utilizing TriNKET technology to target c-Met for NK cell redirection therapy. It comprises three functional components: a single-chain variable fragment (scFV) targeting c-Met, a Fab arm engaging NKG2D, and an Fc fragment directed at NK cell CD16a [1].

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C